AAD 2026Abstract 71668
Early symptom improvement with remibrutinib in chronic spontaneous urticaria
Daily Itch Severity Scores and Hives Severity Scores from phase 3 REMIX-1/-2 studies
Mosnaim G, Staubach P, Yang B, Fukunaga A, Martzloff ED, Chapman-Rothe N, Ding T, Sussman G, Giménez-Arnau AM
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: UrticariaItch & prurigo
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.711 · Not in PubMed: details from Crossref